// App-Quantinova.ai

: Fourth-line targeted therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).

Researchers

Presenter

  • Igor Stukalin

Principal Investigators

  • Anna Paola Fraccon

  • Felice Pasini

  • Camillo Porta

  • Raphael Brandao Moreira

  • Sandy Srinivas

  • I. Alex Bowman

  • James Brugarolas

  • Jae-Lyun Lee

  • Frede Donskov

  • Benoit Beuselinck

  • Aristotelis Bamias

  • Brian I. Rini

  • Hao-Wen Sim

  • Neeraj Agarwal

  • Sun Young Rha

  • Ravindran Kanesvaran

  • Toni K. Choueiri

  • Daniel Yick Chin Heng

Medical Centers

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • Tom Baker Cancer Center - University of Calgary, Calgary, AB, Canada

  • Medical Oncology, Casa di Cura Pederzoli, Peschiera Del Garda, Peschiera Del Garda (VR), Italy

  • Department of Oncology, S Maria della Misericordia Hospital, ULSS 18, Rovigo, Italy

  • IRCCS San Matteo University Hospital Foundation, Padua, Italy

  • Antonio Ermirio de Moraes Oncology Center, Sao Paulo, Brazil

  • Division of Hematology-Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

  • Department of Hematology, Aarhus University Hospital, Aarhus, Denmark

  • Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium

  • Dept of Clinical Therapeutics, University of Athens, Athens, Greece

  • Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

  • Peter MacCallum Cancer Centre, East Melbourne, Australia

  • Huntsman Cancer Institute-University of Utah Health Care, Salt Lake City, UT

  • Yonsei University Kangnam Severance Hospital, Seoul, Republic of Korea

  • National Cancer Centre Singapore, Singapore, Singapore

  • Dana-Farber/Harvard Cancer Center, Boston, MA

Locations

  • Canada

  • Italy

  • Brazil

  • United States

  • Denmark

  • Belgium

  • Greece

  • Australia

  • Singapore

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved